• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Angioedema

Angioedema - 90 Studies Found

Completed : Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
: Hereditary Angioedema
: 2007-04-04
:
  • Drug: ecallantide dose of 30 m

Completed : Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema
: ACE-I and ARB-induced Angioedema.
: 2016-07-05
Active, not recruiting : A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2011-06-28
: Drug: icatibant Single dose of icatibant 0.4 mg/kg subcutaneous(SC) up to a maximal dose of 30 mg
Completed : Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced Angioedema
: Acute ACE-induced Angioedema
: 2013-04-26
:
  • Drug: Berinert
  • Drug: Clemastin

Completed : Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
: Hereditary Angioedema Types I and II
: 2013-04-04
: Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc
Completed : A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2012-02-16
Completed : Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
: Hereditary Angioedema (HAE)
: 2005-12-05
:
  • Drug: ecallantide dose of 30 m

Completed : Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2016-08-10
:
  • Drug: BCX7353 Plasma kallikrei

Completed : Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2014-01-30
:
  • Biological: CINRYZE 500 500 Un

Active, not recruiting : Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)
: Hereditary Angioedema (HAE)
: 2016-08-09
:
  • Drug: CINRYZE 500 U IV infusio

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.